Published in J Neuroendocrinol on February 12, 2010
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int (2014) 2.08
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev (2013) 1.06
Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol (2012) 1.04
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci U S A (2011) 1.02
Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone. Mol Endocrinol (2010) 0.97
Pharmacological chaperoning: a primer on mechanism and pharmacology. Pharmacol Res (2014) 0.92
Chaperoning G protein-coupled receptors: from cell biology to therapeutics. Endocr Rev (2014) 0.91
A novel therapeutic effect of statins on nephrogenic diabetes insipidus. J Cell Mol Med (2015) 0.81
Membrane protein stability analyses by means of protein energy profiles in case of nephrogenic diabetes insipidus. Comput Math Methods Med (2012) 0.80
Using pharmacological chaperones to restore proteostasis. Pharmacol Res (2014) 0.79
Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor. NDT Plus (2011) 0.78
X-Linked Recessive form of Nephrogenic Diabetes Insipidus in a 7-Year-Old Boy. Balkan J Med Genet (2015) 0.75
Evolutionary Influenced Interaction Pattern as Indicator for the Investigation of Natural Variants Causing Nephrogenic Diabetes Insipidus. Comput Math Methods Med (2015) 0.75
A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience (2008) 1.22
Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism. Mol Biol Cell (2005) 1.07
Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus. Am J Physiol Renal Physiol (2006) 1.07
Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model. Am J Physiol Renal Physiol (2005) 1.03
Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell (2004) 0.99
Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res (2007) 0.86
Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology (Berl) (2008) 0.85
Continuous monitoring of ECG in horses at rest and during exercise. Vet Rec (1995) 0.85
Isolation of a novel aquaglyceroporin from a marine teleost (Sparus auratus): function and tissue distribution. J Exp Biol (2004) 0.81
Pyothorax in nine dogs. Vet Q (2000) 0.81
Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels. J Thromb Haemost (2010) 0.79
[Pyothorax in nine dogs]. Tijdschr Diergeneeskd (1999) 0.79
Water in health and disease: new aspects of disturbances in water metabolism. Neth J Med (2007) 0.77
[Percutaneous placement of an esophagostomy tube in cats: first experience with a new technique]. Tijdschr Diergeneeskd (1997) 0.75
A retrospective evaluation of 51 dogs with insulinoma. Vet Q (1998) 0.75
[A comparison of parrot food commercially available in The Netherlands]. Tijdschr Diergeneeskd (1989) 0.75
Response of cats to familiar and unfamiliar human contact using continuous direct arterial blood pressure measurement. Res Vet Sci (2008) 0.75